- Home
- GLDG vs RPTX Comparison
GLDG vs RPTX Comparison
Compare GLDG & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GLDG
- RPTX
- Stock Information
- Founded
- GLDG 2009
- RPTX 2016
- Country
- GLDG Canada
- RPTX Canada
- Employees
- GLDG N/A
- RPTX N/A
- Industry
- GLDG Precious Metals
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- GLDG Basic Materials
- RPTX Health Care
- Exchange
- GLDG Nasdaq
- RPTX Nasdaq
- Market Cap
- GLDG 173.2M
- RPTX 152.4M
- IPO Year
- GLDG N/A
- RPTX 2020
- Fundamental
- Price
- GLDG $0.90
- RPTX $2.97
- Analyst Decision
- GLDG Strong Buy
- RPTX Strong Buy
- Analyst Count
- GLDG 1
- RPTX 1
- Target Price
- GLDG $5.25
- RPTX $10.00
- AVG Volume (30 Days)
- GLDG 794.8K
- RPTX 113.0K
- Earning Date
- GLDG 10-11-2024
- RPTX 11-07-2024
- Dividend Yield
- GLDG N/A
- RPTX N/A
- EPS Growth
- GLDG N/A
- RPTX N/A
- EPS
- GLDG N/A
- RPTX N/A
- Revenue
- GLDG N/A
- RPTX $66,524,000.00
- Revenue This Year
- GLDG N/A
- RPTX $13.36
- Revenue Next Year
- GLDG N/A
- RPTX N/A
- P/E Ratio
- GLDG N/A
- RPTX N/A
- Revenue Growth
- GLDG N/A
- RPTX 18.19
- 52 Week Low
- GLDG $0.75
- RPTX $2.71
- 52 Week High
- GLDG $1.08
- RPTX $8.49
- Technical
- Relative Strength Index (RSI)
- GLDG 45.37
- RPTX 39.57
- Support Level
- GLDG $0.88
- RPTX $2.81
- Resistance Level
- GLDG $0.95
- RPTX $4.05
- Average True Range (ATR)
- GLDG 0.04
- RPTX 0.27
- MACD
- GLDG 0.00
- RPTX -0.08
- Stochastic Oscillator
- GLDG 40.00
- RPTX 16.92
About GLDG GoldMining Inc.
GoldMining Inc is a mineral exploration company with a focus on the acquisition, exploration, and development of projects in Colombia, Brazil, the United States, Canada, and Peru. The principal projects are its La Mina Gold project and its Titiribi Gold-Copper project, located in Colombia, Crucero project, located in Peru, Sao Jorge, Batistao, Boa Vista, located in Brazil, Yellowknife Gold Project, located in the Northwest Territories, Canada, and other projects. The company earns maximum revenue from Canada.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.